Concepedia

Min Hui Wang

MH

Statistics

Publications

39

Citations

2.9K

H-Index

24

Active since

2003

Affiliations

The Ohio State University(Current)

St James's University Hospital

The University of Texas MD Anderson Cancer Center

AstraZeneca (United States)

Cornell University

Min Hui Wang is an author at The Ohio State University specializing in medicine, pharmacology, and materials science.

ORCID

Publications per year

2003–2024

39

Publications

39

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 612 citations · Full text

, , +10

Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase

Zhengming Wang, Xinna Li, Ross Cocklin et al. · Journal of Biological Chemistry · 2003 · 233 citations · Full text

, , +14

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

Farrukh T. Awan, Anna Schuh, Jennifer R. Brown et al. · Blood Advances · 2019 · 185 citations · Full text

, , +7

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results

John C. Byrd, William G. Wierda, Anna Schuh et al. · Blood · 2019 · 178 citations · Full text

, , +10

Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems

Des R. Kashyap, Min Hui Wang, Li-Hui Liu et al. · Nature Medicine · 2011 · 161 citations · Full text

, , +14

1–5 of 39